IL10 and B-cell chronic lymphocytic leukemia: Finally, we analyzed the potential accumulation of MDSCs as an additional source of plasmatic IL-10, and we observed [49] an accumulation of these immunosupresive cells over time in all CLL patients regardless of their clinical evolution, although the degree of increment was higher in progressing patients (Supplementary Fig. S4e).